Delivery Order SPE2DB22D1106-SPE2DB25FFHU0
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,673.88 to AmerisourceBergen Drug Corp for the supply of Trintellix 20 mg tablets (30-count units) on August 19, 2025, with completion targeted for August 20, 2025. This competitively awarded, non-set-aside contract reflects a firm fixed-price delivery order executed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which carries a total value of $999,999,999.00...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,427.12 for 30 tablets of Trintellix 20 mg on July 24, 2025, with an ultimate completion date of July 25, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Trintellix is a psychiatric medication used to treat major depressive disorder, reflecting the breadth...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Trintellix 10 mg tablets (30-count packaging) under a firm fixed-price contract with a ceiling value of $1,309.08. The award, issued on August 1, 2025, with an ultimate completion date of August 4, 2025, represents a non-set-aside competitive award to the prime contractor. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Trintellix 5 mg tablets (30-count) with a contract ceiling value of $4,978.44. This firm fixed-price delivery order represents a non-set-aside competitive award and is scheduled for completion by August 5, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Trintellix 5 mg tablets (30-count packages) valued at $3,315.85. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract reflects AmerisourceBergen's role as a critical pharmaceutical supplier to the federal medical procurement system, particularly for military and veteran healthcare needs. Performance...
- This is a $3,747.43 delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Trintellix 10 mg tablets. The contract has a completion date of May 2, 2022 and is a firm fixed-price agreement. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also does business as AmerisourceBergen. Both companies are for-profit organizations registered in the System for Award...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,442.25, is for the delivery of Trintellix 10 mg tablets. It is a firm fixed-price delivery order contract with an ultimate completion date of April 28, 2025. The contract is not set aside and is open to full and open competition. AmerisourceBergen Drug Corp holds a significant Indefinite...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,208.34 for 30 tablets of Trintellix 20 mg, a prescription antidepressant used to treat major depressive disorder. This firm fixed price delivery order, awarded on August 11, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.99 billion through December 2026. The award involved no set-aside...
- This is a $4,039.61 delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 30-count tablets of the medication Trintellix 10 mg. The award was made on September 13, 2021, with a completion date of September 14, 2021. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between the DLA Troop Support Medical and AmerisourceBergen...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Trintellix 10 mg tablets. The delivery order, valued at $2,635.64, is part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and AmerisourceBergen, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFHU0Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,878.66 to AmerisourceBergen Drug Corp for the supply of Trintellix 10 mg tablets (30-count) on September 9, 2025, with an ultimate completion date of September 10, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the prime contractor's corporate office located in Conshohocken, Pennsylvania. The order represents a small-value transaction under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. This delivery order falls within the company's comprehensive IDC vehicle that enables supply of a broad range of pharmaceutical products and medical commodities to support Defense Health Agency and other federal healthcare programs globally. The company's contract portfolio demonstrates consistent capability to fulfill federal medical supply requirements across multiple therapeutic domains, including neurological treatments such as Trintellix, through competitively awarded vehicles with firm fixed pricing.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.9k | 9/9/25 |